These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7237891)

  • 21. Increased concentrations of serum free fatty acids falsely increase serum thyroxine as determined by competitive protein-binding.
    Pannall PR; Swanepoel E; Bennett JM; Pauw FH
    Clin Chem; 1977 Jun; 23(6):990-3. PubMed ID: 870262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal quinidine binding in survivors of prehospital cardiac arrest.
    Kessler KM; Lisker B; Conde C; Silver J; Ho-Tung P; Hamburg C; Myerburg RJ
    Am Heart J; 1984 Apr; 107(4):665-9. PubMed ID: 6702560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting quinidine protein binding in humans.
    Edwards DJ; Axelson JE; Slaughter RL; Elvin AT; Lalka D
    J Pharm Sci; 1984 Sep; 73(9):1264-7. PubMed ID: 6491948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis.
    Costela JL; Jiménez R; Calvo R; Suárez E; Carlos R
    Acta Anaesthesiol Scand; 1996 Jul; 40(6):741-5. PubMed ID: 8836272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digoxin-quinidine interaction in patients with renal failure.
    Hirschberg R; Schaefer K; von Herrath D; Kreutz G; Kewitz H
    Klin Wochenschr; 1981 May; 59(10):521-2. PubMed ID: 7241953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias.
    Kates RE; Sokoloski TD; Comstock TJ
    Clin Pharmacol Ther; 1978 Jan; 23(1):30-5. PubMed ID: 618708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of uremia, hemodialysis, and nonesterified fatty acids on zomepirac plasma protein binding.
    Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT
    Clin Pharmacol Ther; 1983 Nov; 34(5):681-8. PubMed ID: 6627828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heat inhibition of in vitro lipolysis and 14C ibuprofen protein binding in plasma from heparinized uraemic subjects.
    Pearce GA; Brown KF
    Life Sci; 1983 Oct; 33(15):1457-66. PubMed ID: 6621250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of the binding characteristics of chlorophenoxyisobutyric acid to serum proteins in chronically uremic patients : influence of dialysis and heparine (author's transl)].
    Lacour B; Di Giulio S; Nicolaï A; Drüeke T; Debray M; Boulu RG
    Nephrologie; 1982; 3(1):19-22. PubMed ID: 7088259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of assay procedures used to measure total and unbound concentrations of quinidine.
    Wooding-Scott RA; Darling IM; Slaughter RL
    DICP; 1989 Dec; 23(12):999-1004. PubMed ID: 2690475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of heparin on the lipid level during hemodialysis].
    Nikolaeva NP; Siniukhin VN; Khokhlov AP; Iarmolinskiĭ IS; Stetsiuk EA
    Urol Nefrol (Mosk); 1990; (5):31-3. PubMed ID: 2264204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a rapid ultrafiltration technique for determination of quinidine protein binding and comparison with equilibrium dialysis.
    Ha HR; Vozeh S; Follath F
    Ther Drug Monit; 1986; 8(3):331-5. PubMed ID: 3529516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function.
    Drayer DE; Lowenthal DT; Restivo KM; Schwartz A; Cook CE; Reidenberg MM
    Clin Pharmacol Ther; 1978 Jul; 24(1):31-9. PubMed ID: 657716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diazepam and lidocaine plasma protein binding in renal disease.
    Grossman SH; Davis D; Kitchell BB; Shand DG; Routledge PA
    Clin Pharmacol Ther; 1982 Mar; 31(3):350-7. PubMed ID: 7037263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between quinidine concentrations measured in saliva and erythrocytes, and in serum.
    Yosselson-Superstine S; Yanuka Y; Ishai S
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):181-6. PubMed ID: 7076348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hemodialysis on plasma protein binding of bepridil.
    Pritchard JF; Matzke GR; Opsahl JA; Halstenson CE; Nayak RK
    J Clin Pharmacol; 1995 Feb; 35(2):137-41. PubMed ID: 7751422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of free fatty acids on plasma protein binding of disopyramide in haemodialysis patients.
    Horiuchi T; Johno I; Hasegawa T; Kitazawa S; Goto M; Hata T
    Eur J Clin Pharmacol; 1989; 36(2):175-80. PubMed ID: 2721542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma protein binding of clonazepam in hepatic and renal insufficiency and after hemodialysis.
    Pacifici GM; Viani A; Rizzo G; Carrai M; Rane A
    Ther Drug Monit; 1987 Dec; 9(4):369-73. PubMed ID: 3424402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Protein binding of various cephems in healthy subjects and patients with chronic renal failure].
    Kuroyama M; Kumano K; Tomonaga F; Sakai T; Mashimo S
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):769-77. PubMed ID: 1770637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.